Cargando…

Positron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16α-18F-fluoro-17β-estradiol PET

The most frequently used molecular imaging technique is currently 18F-deoxy-glucose (FDG) positron emission tomography (PET). FDG-PET holds promise in the evaluation of recurrent or residual ovarian cancer when CA125 levels are rising and conventional imaging, such as ultrasound, CT, or MRI, is inco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Yoshio, Kurokawa, Tetsuji, Tsujikawa, Tetuya, Okazawa, Hidehiko, Kotsuji, Fumikazu
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702339/ https://www.ncbi.nlm.nih.gov/pubmed/19527525 http://dx.doi.org/10.1186/1757-2215-2-7

Ejemplares similares

(18)F-FDG/(18)F-FES standardized uptake value ratio determined using PET predicts prognosis in uterine sarcoma
por: Yamamoto, Makoto, et al.
Publicado: (2017)

(18)F-fluoro-2-deoxy-D-glucose positron emission tomography findings of neurolymphomatosis
por: Jung, Yun Hwa, et al.
Publicado: (2014)

Different Prognostic Implications of (18)F-FDG PET Between Histological Subtypes in Patients With Cervical Cancer
por: Rahman, Tasmiah, et al.
Publicado: (2016)

Comparison of Positron Emission Tomography Using 2-[(18)F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[(18)F]-fluorothymidine in Lung Cancer Imaging
por: Wang, Fu-Li, et al.
Publicado: (2016)

Diagnostic value of [(18)F]FDG PET/MRI for staging in patients with ovarian cancer
por: Tsuyoshi, Hideaki, et al.
Publicado: (2020)

Diagnostic value of (18)F-FDG PET/MRI for staging in patients with endometrial cancer
por: Tsuyoshi, Hideaki, et al.
Publicado: (2020)

Early Detection of Erlotinib Treatment Response in NSCLC by 3′-Deoxy-3′-[(18)F]-Fluoro-L-Thymidine ([(18)F]FLT) Positron Emission Tomography (PET)
por: Ullrich, Roland T., et al.
Publicado: (2008)

Ferret Thoracic Anatomy by 2-Deoxy-2-(18F)Fluoro-D-Glucose (18F-FDG) Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Imaging
por: Wu, Albert, et al.
Publicado: (2012)

Diagnostic Value of (18)F-FDG PET/MRI for Revised 2018 FIGO Staging in Patients with Cervical Cancer
por: Tsuyoshi, Hideaki, et al.
Publicado: (2021)

[(18)F]-Fluoro-Deoxy-Glucose Positron Emission Tomography Scan Should Be Obtained Early in Cases of Autoimmune Encephalitis
por: Newey, C. R., et al.
Publicado: (2016)

2-deoxy-2[(18)F]fluoro-D-glucose positron emission tomography–computed tomography in rheumatological diseases
por: Subesinghe, Manil, et al.
Publicado: (2021)

Prognostic value of (18)F-FDG PET in uterine cervical cancer patients with stage IIICr allocated by imaging
por: Isaji, Yuzu, et al.
Publicado: (2023)

Evaluation of Shoulder Disorders by 2-[F-18]-fluoro-2-deoxy-D-glucose Positron Emission Tomography and Computed Tomography
por: Moon, Young Lae, et al.
Publicado: (2010)

Appearance of Adrenal Myelolipomas on 2-deoxy-2-((18)F) fluoro-D-glucose Positron Emission Tomography-Computed Tomography
por: Rowe, Steven P., et al.
Publicado: (2017)

Assessment of diffuse Lewy body disease by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET)
por: Mirzaei, Siroos, et al.
Publicado: (2003)

Myxoid liposarcoma with negative features on bone scan and [18F]-2-fluoro-2-deoxy-D-glucose-positron emission tomography
por: Sakamoto, Akio, et al.
Publicado: (2012)

Background Colonic (18)F-Fluoro-2-Deoxy-D-Glucose Uptake on Positron Emission Tomography Is Associated with the Presence of Colorectal Adenoma
por: Lee, Ko Eun, et al.
Publicado: (2016)

Characteristics of Physiological (18)F-Fluoro-2-Deoxy-D-Glucose Uptake and Comparison Between Cats and Dogs With Positron Emission Tomography
por: Chae, Yeon, et al.
Publicado: (2021)

Positron emitting (18)F-2-deoxy-2-fluoro-D-glucose: potential hot new therapy
por: Mortimer, Joanne E, et al.
Publicado: (2003)

Evaluation of (18)F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy
por: Shoda, H, et al.
Publicado: (2007)

2-Deoxy-2-[F-18]fluoro-D-glucose Joint Uptake on Positron Emission Tomography Images: Rheumatoid Arthritis Versus Osteoarthritis
por: Elzinga, E. H., et al.
Publicado: (2007)

Positron emission tomography agent 2-deoxy-2-[(18)F]fluoro-D-glucose has a therapeutic potential in breast cancer
por: Moadel, Renee M, et al.
Publicado: (2003)

18F-2-Deoxy-2-Fluoro-D-Glucose Positron Emission Tomography: Computed Tomography for Preoperative Staging in Gastric Cancer Patients
por: Youn, Seok Hwa, et al.
Publicado: (2012)

Pancreatic tuberculosis: Evaluation of therapeutic response using F-18 fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography
por: Santhosh, Sampath, et al.
Publicado: (2014)

Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission and computed tomography
por: Esmail, H, et al.
Publicado: (2016)

Paclitaxel-induced dermal hypersensitivity lesions: 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography
por: Biner, Inci Uslu, et al.
Publicado: (2018)

Role of brain 2-[(18)F]fluoro-2-deoxy-D-glucose-positron-emission tomography as survival predictor in amyotrophic lateral sclerosis
por: Canosa, Antonio, et al.
Publicado: (2022)

TMSOTf assisted synthesis of 2’-deoxy-2’-[(18)F]fluoro-β-D-arabinofuranosylcytosine ([(18)F]FAC)
por: Gangangari, Kishore K., et al.
Publicado: (2018)

[(18)F]2-Fluoro-2-deoxy-d-glucose PET/CT in mediastinal masses
por: Rankin, S.
Publicado: (2010)

Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)
por: Miele, Evelina, et al.
Publicado: (2008)

Summary of the Standards, Options and Recommendations for the use of positron emission tomography with 2-[(18)F]fluoro-2-deoxy-D-glucose (FDP-PET scanning) in oncology (2002)
por: Bourguet, P, et al.
Publicado: (2003)

Integrated [(18)F]FDG PET/MRI demonstrates the iron-related bone-marrow physiology
por: Tsujikawa, Tetsuya, et al.
Publicado: (2020)

Role of 2-[(18)F] Fluoro-2-Deoxy-D-Glucose-Positron Emission Tomography/Computed Tomography in the Post-Therapy Surveillance of Breast Cancer
por: Chang, Hong-Tai, et al.
Publicado: (2014)

Potential role of (18)F-2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography imaging in patients presenting with generalized lymphadenopathy
por: Karunanithi, Sellam, et al.
Publicado: (2015)

Metabolic and Functional Evaluation of the Heart and Lungs in Pulmonary Hypertension by Gated 2-[18F]-Fluoro-2-deoxy-D-glucose Positron Emission Tomography
por: Saygin, Didem, et al.
Publicado: (2017)

[(18)F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography Imaging in Oncology: Initial Staging and Evaluation of Cancer Therapy
por: Pauwels, Ernest K.J., et al.
Publicado: (2013)

Use of (18)F‐2‐deoxy‐2‐fluoro‐D‐glucose positron emission tomography/computed tomography for staging thyroid carcinoma in a cat
por: Kang, Seonggweon, et al.
Publicado: (2023)

Attenuation-Corrected vs. Nonattenuation-Corrected 2-Deoxy-2-[F-18]fluoro-d-glucose-Positron Emission Tomography in Oncology, A Systematic Review
por: Joshi, Urvi, et al.
Publicado: (2007)

Positron Emission Tomography With 2-[18F]-Fluoro-2-Deoxy-D-Glucose For Initial Staging Of Hodgkin Lymphoma: A Single Center Experience In Brazil
por: Cerci, Juliano Julio, et al.
Publicado: (2009)

New axillary lymph nodal F-18 fluoro-deoxy glucose uptake in an interim positron emission tomography scan – not always a sign of disease progression
por: Manohar, Kuruva, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_dadqh5pgqkocr8vv195hbu2tda